Can [F-18]afatinib PET/CT be used in identifying NSCLC patients with different EGFR mutational status: tracer quantification and assessment of tumor uptake

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalJournal of Nuclear Medicine
Volume60
Publication statusPublished - 1 May 2019

Cite this